FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

ValueSets, Authority Hl7

31,787 resources

By Version

R2: 0
R2B: 0
R3: 645
R4: 19,478
R4B: 5,119
R5: 6,440
R6: 105

By Realm

none: 1,118
au: 63
be: 130
ca: 50
ch: 392
cl: 220
cr: 9
cz: 157
de: 50
dk: 18
ee: 30
eu: 391
fi: 4
fr: 70
it: 44
kr: 20
nl: 432
no: 6
nz: 9
pl: 70
pt: 3
se: 10
us: 12,201
uv: 16,286
other: 4

Start Prev Rows 5200 - 5400 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Source(s)
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.145.json	Fosnetupitant Palonosetron Injectable	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.146.json	Aprepitant Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.147.json	Rolapitant Injectable	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.148.json	Dexamethasone Oral	active	2022-09	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.149.json	Dexamethasone Injectable	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.150.json	Dexamethasone Drug Implant	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.151.json	Olanzapine Oral	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.152.json	Olanzapine Injectable	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.153.json	Idarubicin Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.154.json	Neurokinin 1 Receptor Antagonist Ingredient	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.155.json	Serotonin Receptor Antagonist Ingredient	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.156.json	Clofarabine Injectable	active	2021-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.157.json	Belinostat Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.158.json	Bortezomib Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.159.json	Cabazitaxel Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.160.json	Carfilzomib Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.161.json	Decitabine Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.162.json	Elotuzumab Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.163.json	Enfortumab Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.164.json	Eribulin Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.165.json	Etoposide Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.166.json	Inotuzumab Ozogamicin Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.167.json	Mitoxantrone Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.168.json	Moxetumomab Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.169.json	Necitumumab Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.170.json	Nelarabine Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.171.json	Temsirolimus Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.172.json	Tisagenlecleucel Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.173.json	Topotecan Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.178.json	Atezolizumab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.179.json	Avelumab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.180.json	Bleomycin Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.181.json	Cemiplimab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.182.json	Cladribine Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.183.json	Daratumumab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.184.json	Durvalumab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.185.json	Emapalumab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.186.json	Fludarabine Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.187.json	Ipilimumab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.188.json	Nivolumab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.189.json	Pembrolizumab Injectable	active	2024-12	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.190.json	Polatuzumab Vedotin Injectable	active	2021-07	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.191.json	Pralatrexate Injectable	active	2021-07	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.192.json	Vincristine Injectable	active	2021-07	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.193.json	Methotrexate Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.194.json	Trastuzumab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.195.json	Mitomycin Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.196.json	Brentuximab Vedotin Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.197.json	Doxorubicin Pegylated Liposomal Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.198.json	Blinatumomab Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.199.json	Trastuzumab Emtansine Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.200.json	Gemtuzumab Ozogamicin Injectable	active	2021-05	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.201.json	Tagraxofusp Injectable	active	2024-12	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.202.json	Axicabtagene Ciloleucel Injectable	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.203.json	BRCA1	active	2023-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.204.json	BRCA2	active	2023-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.205.json	BRCA1 Testing	active	2023-06	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.207.json	Epithelial Ovarian Cancer	active	2024-08	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.208.json	Primary Peritoneal Cancer	active	2022-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.209.json	Fallopian Tube Cancer	active	2022-06	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.210.json	Multigene Panel	active	2023-07	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.211.json	BRCA1 and BRCA2	active	2023-06	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.212.json	BRCA1 and BRCA2 Testing	active	2023-06	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.213.json	BRAF V600	active	2022-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.214.json	BRAF V600 Testing	active	2023-04	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.215.json	Colorectal Cancer	active	2024-08	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.216.json	BRAF V600 Mutation Status	active	2022-01	us	loinc
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.217.json	Cancer Stage I	active	2024-08	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.218.json	Head and Neck Cancer	active	2022-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.219.json	Malignant Melanoma of Skin	active	2022-06	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.220.json	Brain Cancer	active	2022-07	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.221.json	Waldenstrom Macroglobulinemia	active	2024-08	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.222.json	High Emetic Risk Intravenous Antineoplastic Agent	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.223.json	Moderate Emetic Risk Intravenous Antineoplastic Agent	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.224.json	Docetaxel Injectable	active	2024-12	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.225.json	Cyclophosphamide Injectable	active	2022-09	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.226.json	LAG 3 Inhibitor	active	2024-11	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.233.json	Chemotherapy Administration	active	2024-01	us	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.240.json	Pathological N Stage N3c	active	2024-09	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.241.json	Audio Visual Telehealth Encounter	active	2025-01	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.242.json	Moderate or High Emetic Risk Oral Antineoplastic Agent	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.243.json	Minimal to Low Emetic Risk Oral Antineoplastic Agent	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.244.json	Copanlisib Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.245.json	Isatuximab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.246.json	Loncastuximab tesirine Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.247.json	Margetuximab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.248.json	Mirvetuximab soravtansine Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.249.json	Tafasitamab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.250.json	Teclistamab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.251.json	Tisotumab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.252.json	Asparaginase Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.254.json	Belantamab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.255.json	Dostarlimab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.256.json	Mosunetuzumab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.257.json	Tremelimumab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.258.json	Indication for Dexamethasone	active	2025-04	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.260.json	Indication for Olanzapine	active	2025-04	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.261.json	Indication for Dexamethasone	active	2025-04	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.263.json	Indication for Olanzapine	active	2025-04	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.264.json	Prednisone	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.265.json	As Needed PRN	active	2025-04	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.3.266.json	Amivantamab Injectable	active	2025-04	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.200.json	Doxorubicin	active	2020-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.201.json	Epirubicin	active	2020-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.202.json	Capecitabine	active	2023-06	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.203.json	Cyclophosphamide	active	2020-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.204.json	Injectable Fluorouracil	active	2020-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.205.json	Methotrexate	active	2020-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.206.json	Trastuzumab and Biosimilars	active	2020-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.207.json	HER2 Presence in Tissue	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.208.json	Carboplatin	active	2020-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.209.json	Depression Screening for Adult	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.210.json	Long Acting Opioids	active	2020-10	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.211.json	High Fiber Supplement or Diet Education	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.212.json	Dexamethasone	active	2021-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.213.json	Olanzapine	active	2021-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.214.json	Pancreatic Cancer	active	2020-10	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.215.json	Audio Visual Telehealth Encounter	active	2025-02	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.216.json	Telephone Encounter	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.217.json	Telehealth Emergency Department or Initial Inpatient	active	2024-07	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.218.json	Dyspnea Assessment	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.219.json	Nausea or Vomiting Assessment	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.220.json	Karnofsky Performance Status	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.221.json	Referral to Hospice Care	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.222.json	Referral to Palliative Care	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.223.json	Palliative Care	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.224.json	Enrollment in Hospice Care	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.225.json	Advance Directive Including Durable Power of Attorney or Instructional	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.229.json	Minimal Emetic Risk Intravenous Antineoplastic Agent	active	2025-04	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.232.json	Epithelial Ovarian Cancer	active	2023-06	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.233.json	Primary Peritoneal Cancer	active	2022-06	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.235.json	BRCA2 Testing	active	2023-06	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.236.json	Multigene Panel	active	2023-07	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.237.json	BRCA1 Testing	active	2023-06	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.238.json	First Line Drug Therapy for Metastatic Colorectal Cancer	active	2022-01	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.239.json	BRAF V600 Testing	active	2022-01	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.240.json	Cancer Stage 4	active	2022-01	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.241.json	Cancer Stage M1	active	2024-12	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.242.json	High Emetic Risk Intravenous Antineoplastic Agent	active	2022-09	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.243.json	Moderate Emetic Risk Intravenous Antineoplastic Agent	active	2024-10	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.245.json	Antiemetic Agent	active	2025-04	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.247.json	Indication for Dexamethasone	active	2025-04	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.1444.5.249.json	Indication for Olanzapine	active	2025-04	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.2074.1.1.3.json	Race Category Excluding Nulls	active	2024-06	us	oid
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.1002.77.json	Codeine	active	2024-02	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.1004.13.json	Dihydrocodeine	active	2024-02	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.1004.14.json	Nalbuphine	active	2020-03	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4009.json	Malignant Intracranial Neoplasm	active	2024-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4010.json	Malignant Intracranial Neoplasm	active	2023-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4015.json	STEMI	active	2022-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4016.json	STEMI	active	2019-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4017.json	STEMI	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4019.json	Fibrinolytic Therapy	active	2023-02	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4023.json	Cerebral Vascular Lesion	active	2025-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4024.json	Cerebral Vascular Lesion	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4025.json	Cerebral Vascular Lesion	active	2019-02	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4026.json	Closed Head and Facial Trauma	active	2019-02	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4028.json	Aortic Dissection or Ruptured Aortic Aneurysm	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4029.json	Acute Peptic Ulcer	active	2023-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4030.json	Acute Peptic Ulcer	active	2023-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4031.json	Acute Peptic Ulcer	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4032.json	Dementia and Related Intracranial Pathologies	active	2025-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4033.json	Dementia and Related Intracranial Pathologies	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4034.json	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2025-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4035.json	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2022-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4036.json	Active Bleeding or Bleeding Diathesis, Excluding Menses	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4043.json	Dementia and Related Intracranial Pathologies	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4044.json	Aortic Dissection or Ruptured Aortic Aneurysm	active	2022-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4045.json	Oral Anticoagulant Medications	active	2023-02	us	rx
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4046.json	Cardiopulmonary Emergency	active	2025-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4047.json	Cardiopulmonary Emergency	active	2025-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4048.json	Cardiopulmonary Emergency	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4049.json	Mechanical Circulatory Assist Device	active	2024-07	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4050.json	Mechanical Circulatory Assist Device	active	2025-02	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4052.json	Mechanical Circulatory Assist Device	active	2025-02	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4053.json	Pregnant State	active	2022-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4054.json	Pregnant State	active	2024-07	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4055.json	Pregnant State	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3157.4056.json	Major Surgical Procedure	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3566.2.1005.json	Chronic Stable Angina	active	2024-02	us	icd
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3566.2.1006.json	Chronic Stable Angina	active	2023-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.3566.3.1002.json	Chronic Stable Angina	active	2021-04	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1001.json	Hospice Encounter	active	2021-08	us	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1002.json	Hospice Encounter	active	2023-02	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1003.json	Hospice Encounter	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1004.json	Nutrition Services	active	2021-09	us	sct
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1005.json	Nutrition Services	active	2021-08	us	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1006.json	Nutrition Services	active	2022-03	us	vsac
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1007.json	Hospice Care Ambulatory	active	2021-08	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.1008.json	Hospice Care Ambulatory	active	2021-08	us	cms
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1005.json	Office Visit	active	2023-11	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1020.json	Initial Hospital Inpatient Visit	active	2017-05	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1030.json	Discharge Services Hospital Inpatient Same Day Discharge	active	2017-05	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1035.json	Discharge Services Hospital Inpatient	active	2017-05	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1040.json	Outpatient Consultation	active	2024-02	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1050.json	Emergency Department Evaluation and Management Visit	active	2017-05	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1060.json	Nursing Facility Visit	active	2024-02	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1065.json	Discharge Services Nursing Facility	active	2017-05	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1080.json	Home Healthcare Services	active	2024-02	us	cpt
us.nlm.vsac	R4	ValueSet-2.16.840.1.113883.3.464.1003.101.11.1110.json	Preventive Care, Initial Office Visit, 0 to 17	active	2017-05	us	cpt